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HEPATITIS C VIRUS IN MONOZYGOTIC TWINS
Fernando L. GONÇALES JR(1), Raquel S. B. STUCCHI(1), Maria Helena P. PAVAN(1), Rodrigo N. ANGERAMI(1) & Neiva S. L. GONÇALES(2)
SUMMARY
A case of a pregnant patient with chronic hepatitis C who gave birth to monozygotic twins that were infected with HCV is
reported. One of the newborns was positive for HCV-RNA in blood sample collected 12 hours after delivery. The other newborn was
negative for HCV-RNA at birth, but was detected HCV viremia at three months of age. The results have led to the conclusion that one
of the twins was probably contaminated in the intrauterine period, while the other acquired the infection in the perinatal period. Both
were negative for HCV-RNA and for anti-HCV in the serum samples collected at nine months of age. The report describes the
changes in the laboratory tests conducted in mother and twins until 29 months after delivery.
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INTRODUCTION
The hepatitis C virus (HCV) is the main non-A, non-B hepatitis
agent of parenteral transmission, usually by blood transfusions or by
needle sharing among intravenous drug users (IVDU)4,15. These risk
factors are absent in a large number of HCV patients. This indicated that
there were other means of transmission such as vertical and perinatal, as
observed in some cases of neonates born to HCV infected mothers5. The
Centers for Disease Control of the United States Public Health Service
estimated that the probability of HCV perinatal transmission is very low
(5%-6%)5. This case report describes the intrauterine and perinatal
infections of homozygotic twins born to an HCV infected mother.
CASE REPORT
A 39-year-old chronic HCV infected patient underwent a cesarean
surgery to give birth to monozygotic twins having a single placenta. The
mother had acute non-A, non-B hepatitis 7 years ago and the results for
both, the anti-HCV-ELISA (EIA 3rd generation, Abbott Laboratories,
Chicago, Illinois, USA) test as well as the HCV-RNA test (HCV
AMPLICOR, Roche Diagnostic Systems, Nutley, New Jersey, USA),
were positive. It was a confirmed genotype 1 (LIPA-Line Probe Assay-
HCV/Innogenetics) infection. The results of a hepatic biopsy performed
5 years ago indicated chronic persistent hepatitis. The patient had never
been subject to antiviral treatment because the AST (aspartate
aminotransferase), ALT (alanine aminotransferase) and liver function
test results were always normal. The patient denied blood transfusions,
was not a drug addict and was seronegative for hepatitis A virus, hepatitis
B virus and the HIV virus markers.
The twins were healthy at birth and when discharged from hospital
on the third day after delivery, were in a very good condition. They were
breastfed for 9 months. The first blood sample for HCV serological and
virological testing was taken from a peripheral arm vein, 12 hours after
birth. Over a period of 29 months the results obtained were normal for
AST, ALT, alkaline phosphate, gamma glutamil transferase and liver
function tests (LFT). In the table I were demonstrated the results of the
anti-HCV, HCV-RNA tests (copies per mL) in both, mother and children,
during follow-up.
In twins also was confirmed a infection by HCV genotype 1 (LIPA-
Line Probe assay-HCV/Innogenetics).
DISCUSSION
HCV infection is thought to be transmitted by an HCV infected
mother mainly at birth4,14. Although some authors have reported that the
risk for infection is far higher in the case of children born of vaginal
birth than in a cesarean section6,12,14, not all studies show a link between
vaginal delivery and perinatal HCV transmission13. HCV viremia was
detected in the peripheral blood of twin 1 twelve hours after birth which
could mean that is possible that the transmission must have occurred in
the uterus and not by mucocutaneous exposure at the time of delivery.
The mother too, had a detectable viremia, which may have helped to
infect the newborn more easily6. Transmission is absent if the mother is
not viremic13,14 and it occurs more frequently when the mother’s viral
load is greater than 1 million copies/ml. The mother’s viral load was
quite low at delivery and probably this fact could explain the absence of
transmission to both twins in the intrauterine period. In twin 2, viremia
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was absent at birth but an HCV-RNA was observed 6 months later. More
likely, the infection occurred perinatally, as with HIV, by mucocutaneous
exposure to HCV at the time of delivery. If viremia is detected in a 3-
month-old child who was HCV-RNA negative at birth, it could be
considered to be either due to a low viremic level at birth (false negative)
or because the infection had taken place during the first few months10.
Passively acquired HCV antibodies have also been found in
uninfected infants10. In newborns the best manner to diagnose HCV
infection is by the HCV-RNA detection using PCR method. The serum
of an infected newborn may show persistent or intermittent HCV-RNA
positive results, which could lead to a false negative PCR result10. This
situation may have occurred in twin 2 at birth (HCV RNA negative).
The transient presence of anti-HCV antibodies was clearly due to
transplacental passage. In Japan, HCV-RNA positive children born to
HCV infected mothers did not show an increase in ALT or were positive
for anti-HCV8 as shown by our children. Research conducted using
quantitative PCR11 and branched DNA signal amplification15 studies have
shown that higher viremic levels in HCV mothers increased the risk of
vertical transmission. The same was observed in the case of anti-HCV
reagent mothers co-infected with HIV12,15, who had higher concentrations
of HCV-RNA15. Material compiled from various studies have shown
that 18% of the children born to HCV mothers co-infected with HIV
developed HCV infection, while 4.5% of the children born to mothers
infected only with HCV developed HCV4.
Because mother’s viral load at birth was quite low, one could suggest
that the infection might have been installed after birth through
breastfeeding. This transmission is a controversial subject and apparently
is not associated with HCV infection of newborns. Using the PCR
method, some researchers have found HCV particles in the mother’s
milk, however, it is not known if these particles could cause infections7,9
though others have detected a high rate of transmission in children who
have been breastfed12. Breastfeeding by HCV infected mothers has not
been prohibited neither have cesarean births been stimulated1,3.
A case of dizygotic twins born to HIV and HCV infected mothers
was recently reported. One of the twins developed only an HIV infection
while the other twin proved to be only HCV-RNA positive. This difference
in transmission suggests that other viral, genetic or placental factors
helped in increasing the child’s susceptibility to these infections2.
Although HCV-RNA detection may be transient in children born to HCV
infected mothers, it remains unclear whether these infants have truly
cleared infection or will have progressive disease.
The investigation conducted in our study suggests that HCV
transmission was probably intrauterine in the case of twin 1 and perinatal
in the case of twin 2. Although repeated HCV-RNA tests using the PCR
method proved negative in the sample collected from twin 2 at birth, this
could be due to false negative results. A follow-up of these twins would
help evaluate the hepatic damage caused by the same HCV strain in
individuals having the same genetic burden and help provide more
extensive information on the natural history of the hepatitis C virus.
RESUMO
Hepatite pelo vírus C em gêmeos monozigóticos
É relatado o caso de paciente grávida, com hepatite C crônica que
deu à luz dois gêmeos monozigóticos. Um recém-nascido apresentou
positividade para o RNA do vírus da hepatite C (RNA-VHC), no sangue
venoso, coletado de veia periférica doze horas após o parto. O outro
recém-nascido apresentou-se negativo para o RNA-VHC logo após o
nascimento, porém tornou-se RNA-VHC positivo na amostra coletada
aos três meses de idade. Os resultados permitem supor que um dos
gêmeos provavelmente foi contaminado no período intra-uterino,
enquanto o outro adquiriu a infecção no período perinatal. Ambos foram
negativos para a presença do RNA-VHC e para os anticorpos anti-HCV
em todas as  amostras séricas coletadas após os nove meses de idade. Os
exames laboratoriais dos gêmeos não mostraram a presença de infecção
crônica pelo VHC durante o acompanhamento de 29 meses .
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Table 1
Results of laboratory tests conducted during 29 months of follow-up
At Birth 6 Months 9 Months 18-29 Months
A-HCVa RNAb A-HCVa RNAb A-HCVa RNAb A-HCVa RNAb
Mother (+) (+) 32.4 x 103 (+) (+) NDc (+) (+) (+) (+)
Twin 1 (+) (+) 6.2 x 103 (+) (+) 38.5 x 103 (-) (-) (-) (-)
Twin 2 (+) (-) < DLd (+) (+) 5.0 x 103 (-) (-) (-) (-)
a=Anti-HCV antibody using enzyme-linked immunosorbent assay (ELISA); b= HCV RNA detection by PCR - copies/ml (AMPLICOR HCV MONITORTM); c= Not Determined;
d=Detection Limit
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